All Stories

  1. Allergic Eye Disease in Adults: Differences in Clinical Profile Based on the Age of Onset
  2. TFOS DEWS III 管理与治疗报告
  3. Cyclosporin (0.09%) Ophthalmic Solution for the Treatment of Dry Eye Disease – A Narrative Review
  4. Corneal Sensitivity, Sub-Basal Corneal Nerve Plexus, and Tear Neuropeptides in Symptomatic Versus Asymptomatic Visual Display Terminal Users
  5. Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease
  6. Therapeutic Advances in Corneal Scar management: Topical Treatments, Mesenchymal Cell Therapy and Stromal Transplantation
  7. Lacrimal gland organoids: A systematic review on development, characterization, molecular profiling and translational potential in dry eye disease
  8. Clinical Evaluation of TeaRx ™ : A Point of Care Multi-Parameter Tear Film Test for Diagnosis, Stratification, and Prediction of Responsiveness to Cyclosporine A Therapy in Dry Eye Disease
  9. Long-term Clinical Outcomes of Type 1 Keratoprosthesis: A 10-Year Experience
  10. Vernal Keratoconjunctivitis: Toward a Structured, Algorithm-Based Management Strategy
  11. Reply: Large Language Models Use in Dry Eye Disease: Bots and Brains
  12. Proteomic mapping of human Tenon's fascia reveals its biomimetic potential for corneal stromal extracellular matrix reconstruction
  13. Experimental investigation of tensile properties and fracture behavior of ophthalmic sutures under straight, knotted, and looped configurations: Vicryl, nylon, and polypropylene
  14. Polycystic Ovary Syndrome and Dry Eye Disease: A Systematic Review and Meta-Analysis
  15. Dry Eye Disease After Ocular or Systemic Infection: A Systematic Review
  16. The Role of the Boston Keratoprosthesis in Severe Ocular Surface Disease and Autoimmune Diseases
  17. Comparative Analysis of Inflammatory Mediators in Children, Adolescents, and Adults with Vernal Keratoconjunctivitis
  18. Quantitative analysis of conjunctival vascular alterations: Applications in ocular and systemic disease detection
  19. Epithelial and mesenchymal progenitor cells in normal and inflamed human lacrimal glands
  20. TFOS DEWS III: Management and Therapy
  21. 4D Bioprinting of Self‐Morphed Corneal Equivalents Using Smart Hybrid Hydrogels
  22. Assessing the Independent and Combined Effects of Hyperosmolarity and Inflammatory Stress on Human Corneal Epithelial Cells
  23. Laser Photocoagulation for Ocular Surface Keratinization: A Minimally Invasive Modality of Treatment
  24. Preservative Related Ocular Surface Toxicity and the Need for Preservative Free Eye Drops in Ocular Surface Disorders - Recommendations of an Expert Group
  25. Large Language Models Use in Dry Eye Disease: Perplexity AI versus ChatGPT4
  26. Atypical Migratory Serpiginous Corneal Epitheliopathy: Unmasking Herpes Simplex Virus Association
  27. Comparative assessment of structural and tear film alterations in rabbit meibomian gland dysfunction models using chemical and electrocauterization techniques
  28. Symblepharon: A Review of Etiology, Clinical Features, and Management Strategies
  29. Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
  30. The Role of Topical Cyclosporine A in Ocular Surface Inflammatory Disorders
  31. Specificity of Direct Immunofluorescence in Healthy Conjunctival Specimens
  32. Immunological and histopathological changes in alkali burn-induced ocular surface pannus: Implication on success vs. failure of SLET
  33. The burden of antimicrobial resistance in biofilm-forming Staphylococcus spp. from Vernal Keratoconjunctivitis patients' eyes
  34. Adnexal surgeries in eyes with keratoprosthesis: challenges and long-term outcomes
  35. Ocular Mucous Membrane Pemphigoid: Immunomodulation in a Patient with Human Immunodeficiency Virus Infection
  36. Bioprinting of transparent and adhesive corneal patches: Integrating photo-crosslinkable dopamine-conjugated silk fibroin and decellularized cornea matrix for sutureless tissue integration and regeneration
  37. Extracellular vesicles in dry eye disease and Sjögren’s syndrome: A systematic review on their diagnostic and therapeutic role
  38. Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders
  39. Meibum and lid margin microbiome in eyes with chalazion: exploring an infectious aetiology
  40. Risk Factors for Development of Limbal Stem Cell Deficiency After Acute Ocular Burns
  41. Emerging approaches for ocular surface and corneal stromal regeneration: Recent advances and future perspectives
  42. Challenges and advances in ocular mucous membrane pemphigoid (OMMP); from pathogenesis to treatment strategies
  43. Five to Twelve Year Outcomes of Autologous Simple Limbal Epithelial Transplantation
  44. Oral Cyclosporine in Vernal Keratoconjunctivitis: Indications, Outcomes, and Effect on Corticosteroid Use
  45. Effect of different artificial tears on tear film parameters in dry eye disease
  46. Surgical Management of Glaucoma in Eyes with Ocular Cicatricial Pemphigoid
  47. Longitudinal Study of Epibulbar Dermolipomas Over Five-Year Follow-Up: Growth Analysis, Refractive Errors, and Surgical Outcomes
  48. The Human Cornea: Unraveling Its Structural, Chemical, and Biochemical Complexities
  49. Bioprinting a resilient and transparent cornea stroma equivalent: harnessing dual crosslinking strategy with decellularized cornea matrix and silk fibroin hybrid
  50. Bioprinting of anisotropic functional corneal stroma using mechanically robust multi-material bioink based on decellularized cornea matrix
  51. Tear Film and Dry Eye Characteristics as Predictors of Photophobia in 374 Patients with Dry Eye Disease
  52. Association of tear osmolarity and corneal nerves structure in dry eye disease: an in vivo study
  53. Acquired Ankyloblepharon Correction Using Ocular Surface and Tarsal Mucous Membrane Grafting in Cicatrizing Ocular Surface Diseases
  54. Paradigm Shift in Eye Banking: From Tissue Retrieval to Cellular Harvesting and Bioengineering
  55. Experimental Models for Keratoconus: Insights and challenges
  56. Punctal cautery in dry eye disease: A systematic review
  57. Allergen Testing: A Review of the Indications, Procedures, and Limitations in Ocular Allergy
  58. Ocular Mucous Membrane Pemphigoid Presenting as Recurrent Pterygium
  59. Efficacy, safety, and tolerability of lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease
  60. Collagen imaging reveals synergistic effects of sutures and host-donor misalignment on topographical irregularities in penetrating keratoplasty
  61. Case Series: Severe meibomian gland loss in polycystic ovarian syndrome patients on estrogen-progesterone therapy: A case series
  62. Developing a model for aqueous deficient dry eye secondary to periglandular cicatrizing conjunctivitis
  63. Lid Margin Microbiome in Stevens-Johnson Syndrome Patients With Lid Margin Keratinization and Severe Dry Eye Disease
  64. Radiological Imaging of the Lacrimal Gland in Sjogren’s Syndrome: A Systematic Review and Meta-Analysis
  65. Investigation of mechanical strength and structure of corneal graft-host junction
  66. Bone marrow mesenchymal stem cell‐derived extracellular vesicles promote corneal epithelial repair and suppress apoptosis via modulation of Caspase‐3 in vitro
  67. Neutrophil‐driven and interleukin‐36γ‐associated ocular surface inflammation in chronic Stevens–Johnson syndrome
  68. Role of Mesenchymal Stem Cell-Derived Conditioned Medium in Modulating the Benzalkonium Chloride-Induced Cytotoxic Effects in Cultured Corneal Epithelial Cells In Vitro
  69. Tear Film Dynamics in Visual Display Terminal Users: A Review of Impact on Goblet Cells, Lacrimal and Meibomian Gland Function
  70. Revisiting rabbit models for keratoconus: A long-term study on collagenase-induced disease progression
  71. Corneal blindness in the developing world: The role of prevention strategies
  72. Clinical profile and management of ocular superglue injuries: Case series and review of literature
  73. Corneal Topography
  74. Ocular Surface Examination
  75. Slit Lamp Biomicroscopy
  76. Ocular surface pseudoepitheliomatous hyperplasia secondary to allergic eye disease: clinical features and management
  77. Intraoperative collagen imaging of sutured cornea: A way towards managing post-penetrating keratoplasty astigmatism
  78. Impact of Symblepharon Management With Ocular Surface Reconstruction on Scleral Lens Fitting in Eyes With Chronic Cicatrizing Conjunctivitis and Keratopathy
  79. Development and validation of a reliable rabbit model of limbal stem cell deficiency by mechanical debridement using an ophthalmic burr
  80. Corneal blindness in the developing world: The role of prevention strategies
  81. Direct Immunofluorescence Findings and Factors Affecting Conjunctival Biopsy Positivity in Ocular Mucous Membrane Pemphigoid
  82. Identification of subject-specific fibrillar disposition in healthy rabbit cornea through birefringence analysis
  83. Tear film changes in symptomatic versus asymptomatic video display terminal users following computer challenge test
  84. Case Series: Severe meibomian gland loss in polycystic ovarian syndrome patients on estrogen-progesterone therapy
  85. Morphologic variants of Meibomian glands: age-wise distribution and differences between upper and lower eyelids
  86. Human Cornea-Derived Extracellular Matrix Hydrogel for Prevention of Post-Traumatic Corneal Scarring – A Translational Approach
  87. Reply Re: “Cicatricial Entropion in Chronic Cicatrizing Conjunctivitis: Potential Pathophysiologic Mechanisms and Long-Term Outcomes of a Modified Technique”
  88. Simple oral mucosal epithelial transplantation (SOMET) for ocular surface reconstruction in Stevens-Johnson Syndrome: A case report
  89. Investigation of microstructural failure in the human cornea through fracture tests
  90. Response to the comments on: Keratoprosthesis in dry eye disease
  91. Human Lacrimal Gland Derived Mesenchymal Stem Cells – Isolation, Propagation, and Characterization
  92. Demographic profile and clinical characteristics of patients presenting with acute ocular burns
  93. Vortex Keratopathy as a Presenting Feature of Ocular Mucous Membrane Pemphigoid
  94. Successful use of conjunctival flaps to prolong survival of type I keratoprosthesis in severe bilateral chemical burns: two case reports
  95. Cicatricial Entropion in Chronic Cicatrizing Conjunctivitis: Potential Pathophysiologic Mechanisms and Long-Term Outcomes of a Modified Technique
  96. Large dacryops with an ectopic lacrimal ductule following membranous conjunctivitis
  97. Expansion and characterization of human limbus-derived stromal/mesenchymal stem cells in xeno-free medium for therapeutic applications
  98. Repeatability of Non-invasive Tear Film Evaluation in Healthy Rabbit Eyes
  99. Cicatricial entropion in eyes with lid margin mucous membrane grafting
  100. 5-Fluorouracil as a targeted lacrimal gland therapy for chronic Stevens-Johnson syndrome: A pilot study
  101. A review of rabbit models of meibomian gland dysfunction and scope for translational research
  102. A review on drug-induced dry eye disease
  103. Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management
  104. Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines
  105. Benzalkonium chloride-induced dry eye disease animal models: Current understanding and potential for translational research
  106. Contact lenses in dry eye disease and associated ocular surface disorders
  107. Dry eye disease and risk factors for corneal complications in chronic ocular graft-versus-host disease
  108. Evaporative dry eye disease due to meibomian gland dysfunction: Preferred practice pattern guidelines for diagnosis and treatment
  109. Keratoprosthesis in dry eye disease
  110. Lacrimal and meibomian gland evaluation in dry eye disease: A mini-review
  111. Management of cataract in dry eye disease: Preferred practice pattern guidelines
  112. Management of corneal perforations in dry eye disease: Preferred practice pattern guidelines
  113. Newer approaches to dry eye therapy: Nanotechnology, regenerative medicine, and tissue engineering
  114. Optimization and evaluation of tear protein elution from Schirmer’s strips in dry eye disease
  115. Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease
  116. Seeing through tears: Understanding and managing dry eye disease
  117. Tear film microbiome in Sjogren’s and non-Sjogren’s aqueous deficiency dry eye
  118. Unilateral conjunctival concretions associated with chronic inflammation and tear instability
  119. Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial
  120. Incurable Blindness: The Final Frontier in Vision Restoration
  121. Editorial: Cell therapy to tissue engineering: Cutting edge research in ocular surface regeneration
  122. Presentation, aetiology and outcomes of corneal ulceration in Sjogren’s Syndrome
  123. Pre-Clinical Evaluation of Efficacy and Safety of Human Limbus-Derived Stromal/Mesenchymal Stem Cells with and without Alginate Encapsulation for Future Clinical Applications
  124. Relationship of Density, Depth, and Surface Irregularity of Superficial Corneal Opacification with Visual Acuity
  125. Safety and Efficacy of Contact Lenses in Eyes After Simple Limbal Epithelial Transplantation
  126. Case Report: Primary graft failure due to a reversed lenticule in Descemet Stripping Automated Endothelial Keratoplasty
  127. Biomaterials for dry eye disease treatment: Current overview and future perspectives
  128. Tissue Adhesives for the Management of Corneal Perforations and Challenging Corneal Conditions
  129. Conjunctival Lymphangiectasia Simulating Loa Loa
  130. Recent Advancements in Molecular Therapeutics for Corneal Scar Treatment
  131. Repeatability, reproducibility and agreement between three different diagnostic imaging platforms for tear film evaluation of normal and dry eye disease
  132. An In-Vitro Investigation on the Birefringence of the Human Cornea Using Digital Photoelasticity
  133. Salivary gland transplantation for dry eye disease: Indications, techniques, and outcomes
  134. Reply
  135. Case Report: Primary graft failure due to a reversed lenticule in Descemet Stripping Automated Endothelial Keratoplasty
  136. Management of an unresponsive case of HSV keratouveitis with trabeculectomy and DSAEK: A case report
  137. Deep anterior lamellar limbo-keratoplasty for bilateral limbal stem cell deficiency with corneal scarring in chemical injury sequelae: Two case reports
  138. Transcriptomic Profiling of Human Limbus-Derived Stromal/Mesenchymal Stem Cells—Novel Mechanistic Insights into the Pathways Involved in Corneal Wound Healing
  139. Drug-induced pemphigoid: Clinical presentation, diagnosis, and management of gliptin-associated cicatrizing conjunctivitis
  140. Lacrimal gland regeneration: The unmet challenges and promise for dry eye therapy
  141. Scleral contact lenses for optimal visual recovery in a case of severe acid burn with total lagophthalmos
  142. Characterising the tear bacterial microbiome in young adults
  143. Non-invasive Tear Film Assessment in Normal Population: Effect of Age, Sex, and Interparametric Relationship
  144. A Review of the Diagnosis and Treatment of Limbal Stem Cell Deficiency
  145. Lacrimal Gland Insufficiency in Aqueous Deficiency Dry Eye Disease: Recent Advances in Pathogenesis, Diagnosis, and Treatment
  146. Allogeneic simple limbal epithelial transplantation for bilateral limbal stem cell deficiency in chronic vernal keratoconjunctivitis: A case report
  147. Mesenchymal stem cell therapy for alleviating ocular surface inflammation in allergic conjunctivitis
  148. Cytokeratin profile and keratinocyte gene expression in keratinized lid margins of patients with chronic Stevens-Johnson syndrome
  149. Role of AS-OCT in Managing Corneal Disorders
  150. Conjunctival Autograft for Tarsal Keratinization in a Case of Chronic Vernal Keratoconjunctivitis
  151. A multi-parameter grading system for optimal fitting of scleral contact lenses
  152. Drug induced cicatrizing conjunctivitis: A case series with review of etiopathogenesis, diagnosis and management
  153. Role of Anterior Segment-Optical Coherence Tomography Angiography in Acute Ocular Burns
  154. Altered Prostaglandin E Receptor Subtype 3 Expression in Lacrimal Glands of Patients with Chronic Stevens-Johnson Syndrome
  155. A case series of ocular involvement in bullous pemphigoid: clinical features, management, and outcomes
  156. Glaucoma Evaluation and Management in Eyes With Boston Type 1 and Aurolab Keratoprostheses in an Indian Cohort
  157. A multi-parameter grading system for optimal fitting of scleral contact lenses
  158. The role of Tenonplasty in the management of limbal and scleral ischemia due to acute ocular chemical burns
  159. Waves of COVID-19 Pandemic: Effect on Ocular Surface Services at a Tertiary Eye Center in India
  160. Tenon's Patch Graft: A Review of Indications, Surgical Technique, Outcomes and Complications
  161. A case series of ocular involvement in bullous pemphigoid: clinical features, management, and outcomes
  162. Mini-conjunctival autograft combined with deep anterior lamellar keratoplasty for chronic sequelae of severe unilateral chemical burn: A case report
  163. Surgical Management of Unilateral Partial Limbal Stem Cell Deficiency: Conjunctival Autografts versus Simple Limbal Epithelial Transplantation
  164. Amniotic Membrane Granuloma in a Case of Ocular Chemical Injury: Clinical Features, Histopathology, and Outcomes
  165. Clinical Utility of COVID-19 Real Time-Polymerase Chain Reaction Testing of Ocular Tissues of Non–COVID-19 Cornea Donors Deemed Suitable for Corneal Retrieval and Transplantation
  166. Longitudinal Changes in Corneal Epithelial Thickness and Reflectivity following Simple Limbal Epithelial Transplantation: An Optical Coherence Tomography-Based Study
  167. Unilateral Dry Eye Due to Possible Isolated Parasympathetic Denervation of the Lacrimal Gland in a Woman With Hypothyroidism
  168. Ultrastructural study of the lacrimal glands in severe dry eye disease following Stevens-Johnson syndrome
  169. Differential expression of tear film cytokines in Stevens–Johnson syndrome patients and comparative review of literature
  170. Repeatability and Reliability of Different Diagnostic Platforms in Normal Tear Film Evaluation
  171. Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in India
  172. Systemic Immunosuppression in Cornea and Ocular Surface Disorders: A Ready Reckoner for Ophthalmologists
  173. Morphological variants of meibomian glands: correlation of meibography features with histopathology findings
  174. Safety and toxicity of human limbus-derived stromal/mesenchymal stem cells with and without alginate encapsulation for clinical application
  175. Chronic Ocular Sequelae and Subsequent Surgical Interventions in Stevens–Johnson Syndrome After Amniotic Membrane Transplantation
  176. COVID-19 Vaccine Uptake in Patients with Ocular Surface Diseases in India
  177. Lid margin keratinization in Stevens-Johnson syndrome: Review of pathophysiology and histopathology
  178. Proof-of-concept study of electrospun PLGA membrane in the treatment of limbal stem cell deficiency
  179. Isolated keratinising corneal ocular surface squamous neoplasia with multifocal recurrence
  180. High-Resolution Optical Coherence Tomography Angiography Characteristics of Limbal Stem Cell Deficiency
  181. Histopathological Characteristics of Limbal Stem Cell Deficiency Secondary to Chronic Vernal Keratoconjunctivitis
  182. Long term outcome of Tenon’s patch graft in corneal perforation secondary to neurotrophic keratitis: A case report on a 4-year anatomical functional outcome
  183. Environmental and Air Pollution Factors Affecting Allergic Eye Disease in Children and Adolescents in India
  184. Human Umbilical Cord-Derived Mesenchymal Stem Cells Promote Corneal Epithelial Repair In Vitro
  185. A novel diagnostic technique of measuring labial minor salivary gland secretions using sodium fluorescein dye: Implications for patients with dry eyes
  186. Ocular Involvement in Sjögren Syndrome: Risk Factors for Severe Visual Impairment and Vision-Threatening Corneal Complications
  187. Rabbit models of dry eye disease: Current understanding and unmet needs for translational research
  188. Preoperative Labial Mucosa Evaluation as a Deciding Tool for Minor Salivary Gland Transplantation
  189. Human Cadaveric Donor Cornea Derived Extra Cellular Matrix Microparticles for Minimally Invasive Healing/Regeneration of Corneal Wounds
  190. Lacrimal Gland Involvement in Severe Dry Eyes after Stevens-Johnson Syndrome
  191. Long term observation of ocular surface alkali burn in rabbit models: Quantitative analysis of corneal haze, vascularity and self-recovery
  192. Eyelash trichomegaly associated with topical tacrolimus use in a patient with Sjogren’s syndrome
  193. Economic, clinical and social impact of simple limbal epithelial transplantation for limbal stem cell deficiency
  194. Tear secretion from the lacrimal gland: variations in normal versus dry eyes
  195. An Evidence-Based Strategic Approach to Prevention and Treatment of Dry Eye Disease, a Modern Global Epidemic
  196. Genetic Markers for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in the Asian Indian Population: Implications on Prevention
  197. A beginner's guide to mucous membrane grafting for lid margin keratinization: Review of indications, surgical technique and clinical outcomes
  198. Allograft rejection after living-related simple limbal epithelial transplantation
  199. Commentary: Are you blinking enough? – Efficacy of a software to improve blink rate in video display terminal users
  200. Commentary: Ocular graft versus host disease: Need for multidisciplinary care
  201. Commentary: The role of amniotic membrane transplantation in the management of acute ocular chemical burns
  202. Endoscopic visualization-assisted corneal bee sting removal
  203. Impact of follow-up of COVID-19 vaccine uptake in patients with ocular surface diseases: A survey
  204. Temporal trend of microsporidial keratoconjunctivitis and correlation with environmental and air pollution factors in India
  205. Waves of COVID-19 on the sands of time: Impact on Indian ophthalmology
  206. Prevention of Corneal Myofibroblastic Differentiation In Vitro Using a Biomimetic ECM Hydrogel for Corneal Tissue Regeneration
  207. Serial anterior segment optical coherence tomography post autologous simple limbal epithelial transplantation
  208. Simultaneous surgical management of unilateral limbal stem cell deficiency and symblepharon post chemical burn
  209. Epidemic keratoconjunctivitis in India: electronic medical records-driven big data analytics report IV
  210. Cataract Surgery in Dry Eye Disease: Visual Outcomes and Complications
  211. Dry eye disease in children and adolescents in India
  212. Oral mucous membrane grafts for total symblepharon and lid margin keratinisation post Stevens-Johnson syndrome
  213. Minor salivary gland transplantation for severe dry eye disease due to cicatrising conjunctivitis: multicentre long-term outcomes of a modified technique
  214. Palpebral lobe of the human lacrimal gland: morphometric analysis in normal versus dry eyes
  215. Allergic conjunctivitis in children
  216. Stevens Johnson Syndrome: From blisters to blindness!
  217. Not all scars last!
  218. Effect of Topical Anesthesia on the Secretory Activity of the Main Lacrimal Gland
  219. Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency
  220. The Human Lacrimal Gland: Historical Perspectives, Current Understanding, and Recent Advances
  221. Functional Assessment of Transplanted Minor Salivary Glands
  222. Secretory Ductules of the Lacrimal Gland
  223. Correspondence
  224. Indications and prognosis for keratoplasty in eyes with severe visual impairment and blindness due to corneal disease in India
  225. Clinical profile of pterygium in patients seeking eye care in India: electronic medical records-driven big data analytics report III
  226. Endophthalmitis with opaque cornea managed with primary endoscopic vitrectomy and secondary keratoplasty: Presentations and outcomes
  227. Epidemic Keratoconjunctivitis in India: Trend Analysis and Implications for Viral Outbreaks
  228. Big data and the eyeSmart electronic medical record system - An 8-year experience from a three-tier eye care network in India
  229. Chronic cicatrizing conjunctivitis: A review of the differential diagnosis and an algorithmic approach to management
  230. Commentary: Ocular surface involvement heralds graft-versus-host disease: Time to act
  231. Encapsulation of human limbus-derived stromal/mesenchymal stem cells for biological preservation and transportation in extreme Indian conditions for clinical use
  232. Design and Outcomes of a Novel Keratoprosthesis: Addressing Unmet Needs in End-Stage Cicatricial Corneal Blindness
  233. Clinical clues predictive of Stevens-Johnson syndrome as the cause of chronic cicatrising conjunctivitis
  234. Allergic eye disease in children and adolescents seeking eye care in India: Electronic medical records driven big data analytics report II
  235. Authors’ response to: The Perils and Pitfalls of Big Data analysis in medicine
  236. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness
  237. Inflammation, vascularization and goblet cell differences in LSCD: Validating animal models of corneal alkali burns
  238. Limbal Epithelial and Mesenchymal Stem Cell Therapy for Corneal Regeneration
  239. Optical coherence tomography angiography of perilimbal vasculature: validation of a standardised imaging algorithm
  240. Autologous limbal stem cell transplantation: a systematic review of clinical outcomes with different surgical techniques
  241. Controversial role of retinoids in ocular surface disease
  242. Incidence, demographics, types and risk factors of dry eye disease in India: Electronic medical records driven big data analytics report I
  243. Conjunctival Retention Cysts: Outcomes of Aspiration and Sclerotherapy With Sodium Tetradecyl Sulfate
  244. Limbal Stromal Stem Cells in Corneal Wound Healing: Current Perspectives and Future Applications
  245. Learning curve of a trained vitreo-retinal surgeon in sub-retinal injections in a rat model: Implications for future clinical trials
  246. Simple limbal epithelial transplantation (SLET): Review of indications, surgical technique, mechanism, outcomes, limitations, and impact
  247. Glue-assisted retinopexy for rhegmatogenous retinal detachments (GuARD): A novel surgical technique for closing retinal breaks
  248. Commentary: The human amniotic membrane: Fortifying nature's gift to ophthalmology
  249. Limbal ischemia: Reliability of clinical assessment and implications in the management of ocular burns
  250. Effect of Optic Nerve Disinsertion During Evisceration on Nonporous Implant Migration: A Comparative Case Series and a Review of Literature
  251. LVP keratoprosthesis: anatomical and functional outcomes in bilateral end-stage corneal blindness
  252. Chronic Ocular Sequelae of Stevens-Johnson Syndrome in Children: Long-term Impact of Appropriate Therapy on Natural History of Disease
  253. Simple limbal epithelial transplantation (SLET) in failed cultivated limbal epithelial transplantation (CLET) for unilateral chronic ocular burns
  254. Simple limbal epithelial transplantation: Impactful innovation
  255. Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population
  256. Optimizing the role of limbal explant size and source in determining the outcomes of limbal transplantation: An in vitro study
  257. Re: Yu et al.: Risk of visual field progression in glaucoma patients with progressive retinal nerve fiber layer thinning ( Ophthalmology . 2016;123:1201-1210)
  258. Role of Diagnostic Endoscopy in Posterior Segment Evaluation for Definitive Prognostication in Eyes With Corneal Opacification
  259. Reply: amniotic membrane transplantation in Stevens-Johnson syndrome
  260. Re: Jabbarvand et al.: Endophthalmitis occurring after cataract surgery: outcomes of more than 480 000 cataract surgeries, epidemiologic features, and risk factors (Ophthalmology 2016;123:295-301)
  261. Surgical Management of Bilateral Limbal Stem Cell Deficiency
  262. Stevens-Johnson syndrome: The role of an ophthalmologist
  263. Endophthalmitis After Pars Plana Vitrectomy
  264. Simple Limbal Epithelial Transplantation
  265. Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis – A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease
  266. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis – A Comprehensive Review and Guide to Therapy. I. Systemic Disease
  267. Outcome of cataract surgery following simple limbal epithelial transplantation for lime injury-induced limbal stem cell deficiency
  268. Molten metal ocular burn: long-term outcome using simple limbal epithelial transplantation
  269. Descemet Membrane Endothelial Keratoplasty
  270. IKZF1, a new susceptibility gene for cold medicine–related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement
  271. Erratum to: Endophthalmitis in Boston keratoprosthesis: case series and review of literature
  272. Re: Coster et al.: A comparison of lamellar and penetrating keratoplasty outcomes: a registry study (Ophthalmology 2014;121:979-87)
  273. Human limbal biopsy-derived stromal stem cells prevent corneal scarring
  274. Correlation between the histological features of corneal surface pannus following ocular surface burns and the final outcome of cultivated limbal epithelial transplantation
  275. Concise Review: The Coming of Age of Stem Cell Treatment for Corneal Surface Damage
  276. Endophthalmitis in Boston keratoprosthesis: case series and review of literature
  277. Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications
  278. Boston type 1 based keratoprosthesis (Auro Kpro) and its modification (LVP Kpro) in chronic Stevens Johnson syndrome
  279. Unilateral Partial Limbal Stem Cell Deficiency: Contralateral Versus Ipsilateral Autologous Cultivated Limbal Epithelial Transplantation
  280. Transforming ocular surface stem cell research into successful clinical practice
  281. Endothelial Keratoplasty
  282. Dry eyes, are we getting anywhere?
  283. Mucosal Complications of Modified Osteo-odonto Keratoprosthesis in Chronic Stevens-Johnson Syndrome
  284. Keratoconus: All you need to know !
  285. Anatomic and Visual Outcomes of Descemetopexy in Post-Cataract Surgery Descemet's Membrane Detachment
  286. Growth of corneal epithelial cells over in situ therapeutic contact lens after simple limbal epithelial transplantation (SLET)
  287. Successful simple limbal epithelial transplantation (SLET) in lime injury-induced limbal stem cell deficiency with ocular surface granuloma
  288. Cultivated Limbal Epithelial Transplantation in Children With Ocular Surface Burns
  289. In-vivo expansion of autologous limbal stem cell using simple limbal epithelial transplantation for treatment of limbal stem cell deficiency
  290. Porphyria: varied ocular manifestations and management
  291. Successful autologous simple limbal epithelial transplantation (SLET) in previously failed paediatric limbal transplantation for ocular surface burns
  292. Successful management of immunological rejection following allogeneic simple limbal epithelial transplantation (SLET) for bilateral ocular burns
  293. Management, Clinical Outcomes, and Complications of Shield Ulcers in Vernal Keratoconjunctivitis
  294. Boston keratoprosthesis for visual rehabilitation in porphyria cutanea tarda
  295. Clinical and Cytologic Evidence of Limbal Stem Cell Deficiency in Eyes With Long-Standing Vernal Keratoconjunctivitis
  296. Role of topical, subconjunctival, intracameral, and irrigative antibiotics in cataract surgery
  297. Corneal collagen cross-linkage in keratoconus
  298. Corneal Hydrops: an uncommon complication of advanced Keratoconus.
  299. Successful deep anterior lamellar keratoplasty following multiple failed limbal transplantations for chronic ocular burns
  300. Clinical outcomes of xeno-free allogeneic cultivated limbal epithelial transplantation for bilateral limbal stem cell deficiency
  301. International Results with the Boston Type I Keratoprosthesis
  302. Long-term Outcomes of Penetrating Keratoplasty for Keratoconus With Resolved Corneal Hydrops
  303. Anterior Segment Optical Coherence Tomography Features of Acute Corneal Hydrops
  304. Reply
  305. Clinical Outcomes of Repeat Autologous Cultivated Limbal Epithelial Transplantation for Ocular Surface Burns
  306. Simple limbal epithelial transplantation (SLET): a novel surgical technique for the treatment of unilateral limbal stem cell deficiency
  307. Short-term outcome of Boston Type 1 keratoprosthesis for bilateral limbal stem cell deficiency
  308. Clinical Outcomes of Penetrating Keratoplasty After Autologous Cultivated Limbal Epithelial Transplantation for Ocular Surface Burns
  309. Clinical outcomes of xeno-free autologous cultivated limbal epithelial transplantation: a 10-year study
  310. Pediatric Lamellar Keratoplasty
  311. Deep Anterior Lamellar Keratoplasty for Resolved Hydrops
  312. Intracameral Perfluoropropane Gas in the Treatment of Acute Corneal Hydrops
  313. Efficacy and Safety Of Conductive Keratoplasty in Keratoconus
  314. Boston type 1 keratoprosthesis for severe blinding vernal keratoconjunctivitis and Mooren’s ulcer
  315. Chapter-30 Amniotic Membrane Transplantation in Ocular Surface Diseases
  316. Antimicrobial properties of amniotic membrane
  317. Central serous chorioretinopathy after dacryocystorhinostomy operation on the same side
  318. Evaluation of Polymerase Chain Reaction-Based Ribosomal DNA Sequencing Technique for the Diagnosis of Mycotic Keratitis